Literature DB >> 2415646

Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation.

H I Switalska, S Niewiarowski, G P Tuszynski, B Rucinski, A H Schmaier, T A Morinelli, C S Cierniewski.   

Abstract

A method for radioimmunoassay of human thrombospondin was developed. Monospecific precipitating anti-human thrombospondin antibody was raised in rabbits after injection of thrombospondin purified by fibrinogen-agarose chromatography and preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The linear portion of the thrombospondin radioimmunoassay standard curve was 0.5 to 20 ng/ml. Normal platelets and platelet-poor plasma contained 28,900 +/- 14,500 ng thrombospondin per 10(9) platelets and 60.6 +/- 10.7 ng/ml (mean +/- SD), respectively. Using radioimmunoassays for beta-thromboglobulin and thrombospondin antigens, we compared platelet location and secretion of these proteins. Both antigens shared similar distributions in platelet subcellular fractions with the largest amount localized to platelet alpha-granules. With thrombin (0.25 U/ml) as a platelet agonist, 62.4% and 19.5% of total beta-thromboglobulin and thrombospondin, respectively, were secreted from suspensions of washed human platelets. Because only 20% of the total platelet thrombospondin was secreted, further studies were initiated to determine whether the remaining thrombospondin became localized on the activated platelets membrane. 125I-Fab antithrombospondin specifically bound to activated platelets but not to unstimulated platelets. In contrast, 125I-Fab anti-beta-thromboglobulin did not bind to activated platelets. Plasma clearance of human beta-thromboglobulin (half-life fast 7.6 minutes, slow 56.6 minutes) and of human thrombospondin (half-life fast 29.9 minutes, slow 190 minutes) followed a biphasic exponential curve. In conclusion, both beta-thromboglobulin and thrombospondin are located in platelet alpha-granules, but they show a different pattern of secretion and expression on the platelet membrane and plasma clearance.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415646

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  6 in total

1.  Thrombospondin-induced adhesion of human platelets.

Authors:  G P Tuszynski; M A Kowalska
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

2.  Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation.

Authors:  Pallavi Garg; Shiqi Yang; Anguo Liu; Manuel A Pallero; Donald J Buchsbaum; Deane F Mosher; Joanne E Murphy-Ullrich; Simeon E Goldblum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-04-29       Impact factor: 5.464

3.  Thrombospondin-1 (TSP-1) Stimulates Expression of Integrin alpha6 in Human Breast Carcinoma Cells: A Downstream Modulator of TSP-1-Induced Cellular Adhesion.

Authors:  Anitha S John; Vicki L Rothman; George P Tuszynski
Journal:  J Oncol       Date:  2010-07-07       Impact factor: 4.375

4.  Matrix-bound thrombospondin promotes angiogenesis in vitro.

Authors:  R F Nicosia; G P Tuszynski
Journal:  J Cell Biol       Date:  1994-01       Impact factor: 10.539

5.  Interactions of thrombospondin with endothelial cells: receptor-mediated binding and degradation.

Authors:  J E Murphy-Ullrich; D F Mosher
Journal:  J Cell Biol       Date:  1987-10       Impact factor: 10.539

6.  The CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cells.

Authors:  Lakshmi Venkatraman; Lisa Tucker-Kellogg
Journal:  Liver Int       Date:  2013-06-26       Impact factor: 5.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.